London: US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.
Azam Khan calls Modi a Fascist
Don`t rush with the Lokpal :BJP
CBI questions Madhu Koda on Coalgate
Stop govt from appointing new Army chief: BJP to Election Commission